BATM Advanced Communications Ltd, (LON:BVC) says that Ador Diagnostics, the firm’s subsidiary focused on the development and marketing of unique in-vitro molecular diagnostics solutions, has received its first commercial order from a leading Italian distributor of molecular biology and genomics products. Dr. Zvi Marom speaks to Proactive London about the deal and why it's a 'milestone' for the company.
News here too on how first models of the meningitis test (called NATlab) will go into final trials in leading hospitals in the first half of this year.
07 Jan 20